Andrew Lin

Andrew Lin is an Adjunct Clinical Associate Professor at the Victorian Heart Institute (VHI), Monash University, where he conducts advanced research in cardiac imaging and coronary atherosclerosis. He is actively involved in clinical and translational research, particularly in the application of artificial intelligence and radiomics in computed tomography for personalized cardiovascular care.

• Doctor of Philosophy, Monash University (2020)
• Bachelor of Medicine & Bachelor of Surgery, University of Melbourne (2008)
• Bachelor of Medical Science, University of Melbourne (2008)

Dr. Lin's research focuses on the intersection of cardiovascular disease and cutting-edge imaging technologies. His key areas include coronary artery disease, atherosclerosis, cardiac CT, radiomics, and the integration of artificial intelligence for noninvasive phenotyping and risk prediction. His work aims to improve early diagnosis, monitor treatment response, and guide personalized interventions.

His recent publications (2018–2025) demonstrate a consistent trajectory in AI-enhanced cardiac imaging, with emphasis on pericoronary adipose tissue, plaque characterization, and longitudinal monitoring using CT. These studies reflect a strong commitment to innovation in cardiovascular diagnostics and precision medicine.

Dr. Lin has secured multiple research grants as a Primary Chief Investigator, including ongoing and completed projects on AI-driven atherosclerosis imaging and statin effects on plaque. His collaborative network includes leading researchers in cardiology and imaging science.

• Artificial intelligence-enabled quantitative atherosclerosis imaging by computed tomography to guide personalised management of coronary artery disease: a randomised clinical trial (2026–2030)
• Effects of statins on coronary atherosclerotic plaques: longitudinal, radiomics-based precision phenotyping (2023–2024)
• The Association of Patterns of Dyslipidaemia with Coronary Artery Plaque on Computed Tomography Coronary Angiography (2018–2021)

He is affiliated with the Victorian Heart Institute at Monash University, a hub for cardiovascular innovation and research excellence. His lab and team focus on developing AI-powered tools for CT-based cardiovascular risk assessment and plaque analysis, contributing to global efforts in reducing cardiovascular morbidity and mortality.